Academic anti CD19 CAR-T cell therapy for relapsed/refractory B-cell lymphomas in real-world clinical practice: a prospective cohort study - Top-Institutions - MDSpire

Academic anti CD19 CAR-T cell therapy for relapsed/refractory B-cell lymphomas in real-world clinical practice: a prospective cohort study

  • By

  • Natalya E. Konoplya

  • Tatiana M. Doroshenko

  • Katsiaryna Yu. Zharkova

  • Tatyana V. Savich

  • Ihar M. Seviaryn

  • Nadezhda M. Bobrova

  • Alexey A. Beleevsky

  • Eldar Kh. Sarydze

  • Sergey L. Polyakov

  • July 17, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    N.N. Alexandrov National Cancer Centre of Belarus
    N.N. Alexandrov National Cancer Centre of Belarus

    Minsk, Belarus

    Key Differentiators

    • Hematology
    • Oncology
  • #2

    Hospital Clinic of Barcelona
    Hospital Clinic of Barcelona

    Barcelona, Spain

    Key Differentiators

    • Hematology
    • Oncology
  • #3

    First Affiliated Hospital, Zhejiang University School of Medicine
    First Affiliated Hospital, Zhejiang University School of Medicine

    Hangzhou, China

    Key Differentiators

    • Hematology
    • Oncology

Original Source(s)

Related Content